Cargando…

Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma

BACKGROUND: The purpose of this study was to determine the α/β ratio for normal liver with hepatitis by analyzing the toxicity data from patients with unresectable hepatocellular carcinoma treated with helical tomotherapy. METHODS: Between March 2006 and February 2012, 98 patients were eligible for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Son, Seok Hyun, Jang, Hong Seok, Lee, Hyochun, Choi, Byung Ock, Kang, Young Nam, Jang, Jeong Won, Yoon, Seung Kew, Kay, Chul Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641977/ https://www.ncbi.nlm.nih.gov/pubmed/23497395 http://dx.doi.org/10.1186/1748-717X-8-61

Ejemplares similares

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2014)

Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2013)

Identification of Biologically Effective Dose-Volumetric Parameters That Predict Radiation-Induced Hepatic Toxicity in Patients Treated With Helical Tomotherapy for Unresectable Locally Advanced Hepatocellular Carcinoma
por: Song, Jin Ho, et al.
Publicado: (2015)

Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis
por: Choi, Byung Ock, et al.
Publicado: (2008)

Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2015)

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
por: Kwon, Jung Hyun, et al.
Publicado: (2010)

Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy
por: Son, Seok Hyun, et al.
Publicado: (2016)

Identifying the optimal criteria of radiotherapeutic parameters for patients with unresectable locally advanced hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2015)

Molecular Pathogenesis of Radiation-Induced Cell Toxicity in Stem Cells
por: Hur, Wonhee, et al.
Publicado: (2017)

Prognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma: A multicenter analysis in Korea (KROG 14–17)
por: Kim, Myungsoo, et al.
Publicado: (2017)

Application of Helical Tomotherapy for Two Cases of Advanced Hepatocellular Carcinoma
por: Kim, Joon Sung, et al.
Publicado: (2011)

Defining Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated with Stereotactic Body Radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2017)

Defining the optimal dose of radiation in leukemic patients with extramedullary lesions
por: Song, Jin Ho, et al.
Publicado: (2011)

The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer
por: Son, Seok Hyun, et al.
Publicado: (2012)

Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases
por: Jo, In-Young, et al.
Publicado: (2014)

Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy
por: Sung, SooYoon, et al.
Publicado: (2017)

Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07)
por: Cha, Hyejung, et al.
Publicado: (2017)

The Biology of Cancer Stem Cells and Its Clinical Implication in Hepatocellular Carcinoma
por: Yoon, Seung Kew
Publicado: (2012)

Radiation-induced brain injury: retrospective analysis of twelve pathologically proven cases
por: Lee, Dong-Soo, et al.
Publicado: (2011)

Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
por: Oh, Byong Sun, et al.
Publicado: (2013)

Graphene Oxide-Based Memristive Logic-in-Memory Circuit Enabling Normally-Off Computing
por: Kim, Yeongkwon, et al.
Publicado: (2023)

Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma
por: Han, Ji Won, et al.
Publicado: (2021)

Tissue-Resident Lymphocytes: Implications in Immunotherapy for Hepatocellular Carcinoma
por: Han, Ji Won, et al.
Publicado: (2020)

The TGF-β1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients
por: Kim, Ji-Yoon, et al.
Publicado: (2009)

Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2020)

Rapidly Progressing Budd-Chiari Syndrome Complicated by Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2003)

Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy
por: Sung, SooYoon, et al.
Publicado: (2016)

Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
por: Lee, Soon Kyu, et al.
Publicado: (2021)

Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy
por: Han, Ji-Won, et al.
Publicado: (2021)

The role of postoperative pelvic radiation in stage IV rectal cancer after resection of primary tumor
por: Lee, Joo Hwan, et al.
Publicado: (2012)

Effects of gold nanoparticles on normal hepatocytes in radiation therapy
por: Kim, Jeong-Yub, et al.
Publicado: (2022)

Unexpected Improvement of Liver Function by Intravenous Immunoglobulin in a Steroid-Experienced Severe Alcoholic Hepatitis
por: Tak, Kwon Yong, et al.
Publicado: (2020)

Impact of radiation on immune cells in patients with low-grade brain tumor: Identifying critical factors affecting lymphopenia and neutrophil-to-lymphocyte ratio
por: Choi, Yoo Kyung, et al.
Publicado: (2023)

Increase of Plasma IL-12/p40 Ratio Induced by the Combined Therapy of DNA Vaccine and Lamivudine Correlates with Sustained Viremia Control in CHB Carriers
por: Im, Se Jin, et al.
Publicado: (2009)

Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose
por: Kwak, Yoo-Kang, et al.
Publicado: (2017)

Therapeutic effect of topical application of curcumin during treatment of radiation burns in a mini-pig model
por: Kim, Joongsun, et al.
Publicado: (2016)

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020)

Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2015)

Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
por: Jang, Jeong-Won, et al.
Publicado: (2021)

Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Ji-Yoon, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b2l4m1h71e75h0blm69ofkv3ku